Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
KPJ Healthcare Berhad (5878.KL)
Kuala Lumpur, MY
KPJ Healthcare Berhad functions as an investment holding company, primarily engaged in the management and operation of an extensive network of specialized hospitals both within Malaysia and across international markets including Indonesia, Thailand, and Bangladesh. Beyond its core hospital services, the company offers a comprehensive array of healthcare and support provisions. These include advanced pathology and laboratory diagnostics, specialized ophthalmic medical and consultancy services, and essential maintenance for both hospital facilities and medical equipment. Its diverse portfolio also spans the operation of various care centers such as polyclinics, dialysis units, facilities for aged care, assisted living, post-natal recovery, and rehabilitation, alongside developing and managing retirement village complexes and ambulatory care centers. KPJ further contributes to healthcare education through its private university college for nursing and allied health professions. The company's commercial activities extend to retail pharmacies, the distribution and marketing of medical, pharmaceutical, and consumer healthcare products, and providing information technology solutions encompassing healthcare information systems and human resource management software rentals. Additionally, KPJ provides internal operational support services like human resource management, building maintenance, sterile processing, laundry, central kitchen operations, and training. Geographically, in addition to its hospital footprint, KPJ operates senior and assisted living care facilities in both Malaysia and Australia. The company was founded in Kuala Lumpur, Malaysia, in 1981, where its headquarters are located.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +0.00% | -4.83% | -4.55% | +9.76% | +17.54% | +17.10% | +6.06% | +178.76% | +215.00% | +200.00% | +3,991.71% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 2 | 0 |
| Buy | 8 | +1 |
| Hold | 7 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Medical - Care Facilities: +10.2%+8.6% Q1'26: +8.0% (vs Q1'25)
-
EPS growth Medical - Care Facilities: +19.2%+3.0% Q1'26: +19.8% (vs Q1'25)
-
FCF margin FCF growth · Medical - Care Facilities: +32.0%+8.5% Q1'26: -1.4% (vs Q1'25)
-
EBIT margin Medical - Care Facilities: +11.3%+15.3% ★ Q1'26: +15.1% (vs Q1'25)
-
ROIC Medical - Care Facilities: +6.8%+7.8% ★ Q1'26: +7.5% (vs Q1'25)
-
Share dilution Medical - Care Facilities: +0.0%+0.3% Q1'26: +1.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×4.12× Q1'26: 4.12× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2015 actual |
Dec 2016 actual |
Dec 2017 actual |
Dec 2018 actual |
Dec 2019 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 14 Rev. Ana. 14 EPS Ana. |
Dec 2027 16 Rev. Ana. 16 EPS Ana. |
Dec 2028 14 Rev. Ana. 15 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.83B
est: 2.91B (-2.8%)
|
2.99B
est: 3.04B (-1.8%)
|
3.14B
est: 3.27B (-4.0%)
|
3.27B
est: 3.46B (-5.4%)
|
3.57B
est: 3.57B (-0.2%)
|
2.36B
est: 3.25B (-27.4%)
|
2.63B
est: 2.59B (+1.5%)
|
2.92B
est: 2.91B (+0.5%)
|
3.42B
est: 3.36B (+1.8%)
|
3.92B
est: 3.83B (+2.3%)
|
4.26B
est: 4.16B (+2.4%)
|
4.56B
4.31B – 4.79B
+9.7% YoY
|
4.90B
4.33B – 5.79B
+7.4% YoY
|
5.29B
4.83B – 5.92B
+8.0% YoY
|
| EBITDA |
392.93M
est: 674.65M (-41.8%)
|
432.90M
est: 704.42M (-38.5%)
|
444.24M
est: 758.74M (-41.4%)
|
469.29M
est: 801.88M (-41.5%)
|
654.82M
est: 828.63M (-21.0%)
|
553.04M
est: 753.89M (-26.6%)
|
513.18M
est: 600.25M (-14.5%)
|
683.10M
est: 673.48M (+1.4%)
|
814.46M
est: 778.70M (+4.6%)
|
1.01B
est: 1.02B (-1.3%)
|
962.11M
est: 1.11B (-13.3%)
|
1.22B
1.15B – 1.28B
+9.7% YoY
|
1.31B
1.16B – 1.54B
+7.4% YoY
|
1.41B
1.29B – 1.58B
+8.0% YoY
|
| EBIT |
273.77M
est: 420.37M (-34.9%)
|
300.88M
est: 438.92M (-31.4%)
|
313.28M
est: 472.77M (-33.7%)
|
311.47M
est: 499.65M (-37.7%)
|
434.56M
est: 516.32M (-15.8%)
|
314.29M
est: 469.75M (-33.1%)
|
264.27M
est: 374.02M (-29.3%)
|
424.39M
est: 419.65M (+1.1%)
|
539.14M
est: 485.20M (+11.1%)
|
727.98M
est: 847.98M (-14.2%)
|
651.31M
est: 920.22M (-29.2%)
|
1.01B
954.40M – 1.06B
+9.7% YoY
|
1.08B
957.52M – 1.28B
+7.4% YoY
|
1.17B
1.07B – 1.31B
+8.0% YoY
|
| Net Income |
135.33M
est: 155.90M (-13.2%)
|
149.20M
est: 142.90M (+4.4%)
|
161.91M
est: 151.92M (+6.6%)
|
179.44M
est: 180.53M (-0.6%)
|
211.37M
est: 191.47M (+10.4%)
|
110.44M
est: 130.98M (-15.7%)
|
51.03M
est: 62.29M (-18.1%)
|
166.98M
est: 141.91M (+17.7%)
|
263.41M
est: 231.05M (+14.0%)
|
353.82M
est: 305.82M (+15.7%)
|
365.93M
est: 330.84M (+10.6%)
|
402.61M
375.42M – 457.39M
+21.7% YoY
|
448.24M
409.40M – 534.21M
+11.3% YoY
|
493.59M
437.60M – 569.10M
+10.1% YoY
|
| SGA |
644.62M
est: 812.76M (-20.7%)
|
687.84M
est: 848.62M (-18.9%)
|
731.52M
est: 914.05M (-20.0%)
|
742.24M
est: 966.03M (-23.2%)
|
751.99M
est: 998.25M (-24.7%)
|
647.35M
est: 908.22M (-28.7%)
|
728.38M
est: 723.12M (+0.7%)
|
796.24M
est: 811.35M (-1.9%)
|
980.26M
est: 938.10M (+4.5%)
|
1.12B
est: 1.08B (+3.3%)
|
1.25B
est: 1.18B (+5.9%)
|
1.29B
1.22B – 1.35B
+9.7% YoY
|
1.39B
1.22B – 1.64B
+7.4% YoY
|
1.50B
1.37B – 1.67B
+8.0% YoY
|
| EPS |
0.03
est: 0.04 (-8.7%)
|
0.03
est: 0.03 (+4.8%)
|
0.04
est: 0.03 (+6.3%)
|
0.04
est: 0.04 (-10.3%)
|
0.05
est: 0.04 (+12.8%)
|
0.03
est: 0.03 (-14.0%)
|
0.01
est: 0.01 (-16.6%)
|
0.04
est: 0.03 (+18.4%)
|
0.06
est: 0.05 (+14.1%)
|
0.08
est: 0.07 (+16.2%)
|
0.08
est: 0.08 (+10.7%)
|
0.09
0.09 – 0.10
+21.7% YoY
|
0.10
0.09 – 0.12
+11.3% YoY
|
0.11
0.10 – 0.13
+10.1% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-26 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-25 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-22 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-21 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-20 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-19 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-18 | B | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 1/5 | 2/5 |
| 2026-05-15 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-14 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-13 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-12 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-11 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-08 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-07 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-06 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-05 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-05-04 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-30 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-29 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-28 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-27 | B+ | 3/5 | 5/5 | 4/5 | 4/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-24 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-23 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-22 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-21 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-20 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-17 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 5/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | iShares Ageing Population UCITS ETF AGED.L | 0.12% | 1.05M | 0.40% |
| 2 | iShares MSCI AC Far East ex-Japan Small Cap UCITS ETF ISFE.L | 0.11% | 82.5K | 0.74% |
| 3 | iShares MSCI EM Small Cap UCITS ETF IEMS.L | 0.09% | 309.4K | 0.74% |
| 4 | iShares MSCI Emerging Markets Small-Cap ETF EEMS | 0.07% | 278.8K | 0.72% |
| 5 | State Street SPDR MSCI Emerging Markets Small Cap UCITS ETF EMSD.L | 0.07% | 442.7K | 0.55% |
| 6 | Vanguard FTSE All-World ex-US Small-Cap ETF VSS | 0.05% | 6.81M | 0.06% |
| 7 | Dimensional - Emerging Markets High Profitability ETF DEHP | 0.04% | 185.7K | 0.44% |
| 8 | Avantis Responsible Emerging Markets Equity ETF AVSE | 0.03% | 65.1K | 0.33% |
| 9 | Xtrackers Emerging Markets Carbon Reduction and Climate Improvers ETF EMCR | 0.02% | 12.6K | 0.15% |
| 10 | Dimensional - Emerging Markets ex China Core Equity ETF DEXC | 0.02% | 58.7K | 0.56% |
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Keat Chyuan Chin | President, MD & Director | 7M | male |
| Maisarah Binti Omar | Regional Chief Executive Officer of Southern & East Malaysia Malaysian | — | female |
| Mohd Farid Bin Mohd Salim FCCA | Chief Operating Officer of Hospital Operations | — | male |
| Mohd Khairul Izzad Bin Mohammed Shamsudin | Chief Financial Officer | — | male |
| Nik Fawaz Bin Nik Abdul Aziz | Chief Operating Officer Group Allied & Retail Health Operations | — | — |
| Norhamijah Mohd Hanafiah | Chief Human Resource Officer | — | female |
| Renuga Muniandy | Covering Regional Chief Executive Officer of Northern & East Coast Region | — | female |
| Sharizul Hasnifa Bin Baseri | Chief Risk Officer | — | male |
| Elena Binti Shamsuddin | Chief of Staff & Head of Group Strategic Communication | — | female |
| Syed Iskandar Shah Bin Syed Abu Bakar | Head of Legal and Advisory | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 5878.KL
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
